Abstract
Diffuse alveolar hemorrhage is a clinical syndrome that can be a manifestation of multiple different causes. Identification of the underlying etiology is of utmost importance and dictates treatment. Pulmonary vasculitis including antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a common cause of diffuse alveolar hemorrhage. For AAV, treatment includes induction followed by maintenance therapy. Rituximab has an increasing role in the treatment of AAV.
Original language | English (US) |
---|---|
Pages (from-to) | 587-600 |
Number of pages | 14 |
Journal | Immunology and Allergy Clinics of North America |
Volume | 32 |
Issue number | 4 |
DOIs | |
State | Published - Nov 2012 |
Keywords
- ANCA-associated vasculitis
- Diffuse alveolar hemorrhage
- Eosinophilic granulomatosis with polyangiitis
- Granulomatosis with polyangiitis
- Microscopic polyangiitis
- Pulmonary vasculitis
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology